Management Board

Paweł
Roszczyk

Member of the Management Board
at Adamed Pharma S.A.,
Managing Director

Graduate of the Foreign Trade Faculty at the Warsaw School of Economics, with a master’s degree in economics, and the Institute of Economics and Commercial Law at Taras Shevchenko National University of Kyiv.Before joining Adamed, he gained extensive professional experience working for financial institutions. Between 1997 and 2008, he worked at the Pekao S.A. Central Brokerage House,

where his career path led him from Analyst, through Project Manager and later Head of the Issue Preparation Team, to Director of the Capital Markets Department.

In 2008, he joined UniCredit CAIB Poland S.A., first as the Executive Director at the Investment Banking Division of Markets & Investment Banking and later as the Managing Director at the Investment Banking Division of UniCredit Group Corporate & Investment Banking.

He has worked for shareholders and management boards of sector-leading companies, including but not limited to: Netia, Globe Trade Centre, TVN, Cyfrowy Polsat, Dom Development, Mercor, Ferro, Tracktec, and Adamed. He has advised on the privatisation processes of Bank Pekao, the Warsaw Stock Exchange, Tauron Polska Energia, and PGE, to name a few.

At Adamed Pharma, he has been serving as the Managing Director since 2012. He is co-responsible for strategy development and supervision of its implementation. He oversees key projects and participates in making strategic investment decisions and their financing.

 

Magdalena Tomaszewska

Member of the Management Board,
at Adamed Pharma S.A.,
Director of Business Operations

Magdalena Tomaszewska is a graduate of pharmacy from the Medical Academy in Warsaw (currently Medical University of Warsaw) and MBA studies at the International School of Management in Warsaw (currently Kozminski University). She has a first-degree specialization in clinical analytics. Her career has been linked to the pharmaceutical industry for over 25 years.

She has built up her professional experience in Poland and abroad. She has worked for global pharmaceutical companies both in the segments of innovative and generic drugs.

Throughout her career, she has completed a number of training programs focused on management, strategic planning and finance, both in Europe and the USA.

Between 2005 and 2010, she held the role of General Manager for Poland at Ratiopharm. In 2010-2017, she worked in the international structures of Glenmark Pharmaceuticals, initially managing the company's operations on the Central and Eastern European markets, followed by the whole of Europe, Russia, CIS, Asia, and South America. After returning to Poland in 2017, she joined PGF SA as President of the Executive Board and CEO.

At Adamed Pharma, she has been serving as Director of Business Operations since 2020. She is co-responsible for the development and deployment of Adamed's global strategy, and for the company's successful adaptation to the changing environment. Among other fields of expertise, she is responsible for marketing, sales and distribution management both in Poland and on international markets.

 

Tomasz
Krzak

Member of the Management Board
at Adamed Pharma S.A.,
HR Director

He graduated from the prestigious Senior Executive Programme at London Business School. He studied HR during postgraduate studies at the Warsaw School of Economics. He also graduated from journalism at the Jagiellonian University in Krakow, and holds a master’s degree in law from the University of Silesia. He brings more than 18 years of professional experience in HR management

from both Polish and international organisations.

During his career, he was responsible for Poland, the CEE markets and the Baltics. He started his career in HR in the Paints and Varnishes Plant ŚNIEŻKA SA. In 2003, together with the Management Board of ŚNIEŻKA SA, he completed the company’s IPO on the stock exchange. Between 2005-2011, he was the HR Director responsible for change management and for the relationship with the social partner at Fresenius Kabi, the international pharmaceutical conglomerate. He then moved to L’OREAL Group where he worked as the HR Director until 2013.

He has been the director in charge of the Human Resources Management Sector at Adamed Pharma since early 2014. Over the last few years, he has been establishing Adamed’s growth strategy and participating in the development of global strategic- and operational plans within his area of responsibility. He has been successfully building an engaging workplace and creating a corporate culture based on the company’s values and founder’s mentality. He is responsible for creating and implementing transparent processes for all key activities in the organization.

A Member of the Management Board at Adamed Pharma S.A. since January 2017.

 

Sylwia
Berdzik-Kalarus

 

Member of the Management Board
at Adamed Pharma S.A.,
Head of Business Development
& Product Portfolio Management

She graduated from the Faculty of Pharmacy of the Medical College of the Jagiellonian University, with 1st degree specialization in Retail Pharmacy. Her career has been linked to the pharmaceutical industry for over 15 years. She has gained her experience in both original and generic companies (Servier, Ipsen, Adamed and Egis), initially in sales, then in the field of operating marketing and now in the business development area.

She has worked for Adamed since 2013. She initially built the Strategic Marketing structures and since 2016 she has been responsible for the entire Adamed Business Development and Product Portfolio Management Department. In her current position, she is directly responsible for creating the global Adamed pipeline, as well as for the Procurement, Out-Licensing and Strategic Alliance Departments. She is also in charge of the management of the Innovation Department as regards the coordination and shaping of a global strategy of development and commercialization of innovative molecules in the CNS, oncology and diabetology areas.

As Head of Business Development & Product Portfolio Management she is co-responsible for the development and execution of Adamed’s international strategy to meet business expectations and ensure alignment with the evolving market environment.

 

Bartłomiej Rodawski,
PhD in Economics

Member of the Management Board
at Adamed Pharma S.A.,
Chief Operating Officer

Graduate of the Wroclaw University of Economics and Business, where he was awarded his PhD in Economics in 2002. Holder of a scholarship in Project Planning and Analysis at the University of Bradford, granted by the UK Government (2005). In 2000–2009, a university lecturer at the Wroclaw University of Economics and Business, as well as WSB University in Wrocław, among others.

An experienced manager, he has worked in the pharmaceutical sector since 2003. In 2006–2008, he held the role of Managing Director of the Polish-German Research Association (EEIG). Since 2017, he has been a Member of the Board of Directors at Davipharm. In 2018–2020, he held the role of Member of the Economic Council of the Lodz Province.

Bartłomiej Rodawski has authored more than a dozen articles on supply chain management in the pharmaceutical sector, as well as a report called: “Supply Chain Management in the Pharmaceutical Sector in Poland in 2008” which was published by PMR Institute. Throughout his professional career, he has run analytical, training and implementation projects in the pharmaceutical, FMCG, logistics and service sectors.

He has worked at Adamed since 2009. Since 2013, he has been a Member of the Management Board and Chief Operating Officer. He is in charge of the co-development and implementation of the strategy for the development of broadly understood supply chain, including production, quality, logistics, and technology.

 

Tomasz
Podgórski

Member of the Management Board
at Adamed Pharma S.A.,
Chief Financial Officer

Graduate of Warsaw School of Economics (SGH) in the field of Finance and Banking. He also graduated from the Faculty of Law at the University of Warsaw and holds the Undergraduate Diploma of the University of Cambridge in the field of English and EU Law. He is currently participating in the INSEAD Global Executive MBA programme.

Between 2006-2017, he was associated with leading investment banks, such as: BNP Paribas (2006), Rothschild (2007-2008) and UniCredit (2008-2015 in Warsaw, 2015-2017 in Vienna), where he dealt with M&A transactions in the areas of health care, pharmacy and consumer goods.

At Adamed Pharma since 2017. As the CFO, he is co-responsible for shaping and implementing financial and international strategies, introducing technological tools, including the use of modern cloud solutions, and effective management of the Financial Area, which comprises: Controlling, Liquidity Management, Accounting, Procurement, IT and Data Management.

 

Marcin
Celejewski

Member of the Management Board
at Adamed Pharma S.A.,
Head of Innovative Business Projects

He graduated from the Management and Marketing Program at the Warsaw School of Economics, specializing in Strategic Management.He has gained his professional experience in Poland and abroad, sitting on the management boards and holding executive positions in companies such as: PLL LOT, PKP Intercity, Ukrainian Railways, Qatar Airways, Kenya Airways and Fiege GmbH.

He has been responsible for devising and implementing innovative development strategies aimed to achieve ground-breaking changes in the performance and market perception of companies operating in dynamic and very competitive markets.

The key achievements of the teams he has managed include the launch of a new entity, Quatar Executive, in 2010; an overhaul of the commercial and pricing strategy of Fiege Polska in 2012; implementation of customer, quality, finance and image-related changes at PKP Intercity, which resulted in the roll-out of Pendolino trains in Poland in 2015; the completion and initial implementation of the expansion strategy of LOT in 2016 and the preparation of a customer care revolution and digitization strategy for Ukrainian Railways in 2020.

He has been the Head of Innovative Business Projects at Adamed Pharma since December 2020. His responsibilities include identifying and evaluating projects to support the implementation of Adamed’s strategy.